Compare American Homes 4 Rent Class A (AMH) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Homes 4 Rent Class A vs Enveric Biosciences Inc — how do they compare? American Homes 4 Rent Class A trades at $33.92 (market cap $12.28B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: American Homes 4 Rent Class A is far larger — about 1980.6× Enveric Biosciences Inc's market cap, and American Homes 4 Rent Class A pays a 3.87% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| AMH | ENVB | |
|---|---|---|
Market Cap | $12.28B | $6.20M |
Sector | Real Estate | Health |
52-Week High | $35.82 | $17.40 |
52-Week Low | $27.38 | $1.27 |
Enterprise Value | $17.35B | $1.30M |
Dividend Yield | 3.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMH (American Homes 4 Rent) trades at $34.63, up 0.23% with strong technical momentum and bullish moving averages. The REIT demonstrates robust fundamentals with consistent revenue growth from $1.5B in 2022 to $1.85B in 2025, net income margin expansion to 25.53%, and three consecutive quarterly EPS beats. Recent Q2 2026 results exceeded FFO estimates, prompting raised full-year guidance. Institutional activity shows mixed positioning while analyst consensus remains positive with a $36.45 price target.
AMH presents a compelling opportunity with strong operational execution in the single-family rental market, though investors face risks from regulatory changes affecting institutional home ownership and elevated debt levels. The stock's current valuation at 27.48 P/E appears reasonable given growth trajectory, but monitoring legislative impacts and interest rate sensitivity remains crucial for sustained performance.
ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.
Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Homes 4 Rent Class A
American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas
Read more on AMH →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
